We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Panel Struggles to Agree on Effectiveness of Tumor Device
FDA Panel Struggles to Agree on Effectiveness of Tumor Device
March 18, 2011
An FDA advisory panel reached deadlock over the effectiveness of a novel device that blasts glioblastoma multiforme (GBM) brain tumors with an electrical field, with the panel chair breaking the tie in favor of the device.